Skip to content

Telerehabilitation in Duchenne Muscular Dystrophy

Remote Physiotherapy Application to Protect Physical Health in Duchenne Muscular Dystrophy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05305976
Acronym
Duchenne
Enrollment
43
Registered
2022-03-31
Start date
2021-01-11
Completion date
2022-01-01
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy

Keywords

Duchenne Muscular Dystrophy, telerehabilitation, satisfaction

Brief summary

Duchenne Muscular Dystrophy (DMD) is a progressive inherited disease that affects the muscles and causes functional limitations to varying degrees. It is vital to start physiotherapy follow-ups immediately after diagnosis. Patients with DMD are among the most vulnerable groups who have problems in accessing physiotherapy services during the COVID-19 pandemic. The aim of the study was to investigate the effects of the telerehabilitation program developed to protect the physical health of patients with DMD and not to interrupt their follow-up.

Detailed description

Forty two patients with DMD were included in the study. 30 of them were ambulant in group 1, and 12 were non-ambulant in group 2. Physiotherapy assessments were performed blindly before the program started. According to the functional levels of the individuals, 2 groups were formed. 9 physiotherapists applied the tele-rehabilitation program for 24 session (3 days in a week).

Interventions

OTHERTelerehabilitation

The 8 week exercise program with telerehabilitation

Sponsors

Karadeniz Technical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Grup 1: Ambulant Group Grup 2: Non-ambulant Group

Eligibility

Sex/Gender
MALE
Age
5 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able to communicate verbally and visually * Older than 5 years old

Exclusion criteria

* The children who had undergone any surgical operations in the past 6 months, * Having a severe cognitive and breathing impairment * Using mechanical ventilator continually or intermittent * Having a febrile infection

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary Dysfunction Test (After intervention)After the intervention, average two weeks.Value when the patient counts audibly in a single expiration after maximum inspiratory effort
Functional levelBefore the intervention, up to one monthBrooke Function Classification System
Socio-demographicsBefore the intervention, up to one monthgender, body weight, height
Walking test (Before intervention)Before the intervention, up to one month.The distance of 10 m was determined in a suitable indoor environment.
Walking test (After intervention)After the intervention, average two weeks.The distance of 10 m was determined in a suitable indoor environment.
Time to stand up from the supine position (Before intervention)Before the intervention, up to one month.The time to stand up from the supine position was recorded.
Time to stand up from the supine position (After intervention)After the intervention, average two weeks.The time to stand up from the supine position was recorded.
Modified upper extremity performance test (Before intervention)Before the intervention, up to one month.Flexion the shoulder to 90 degrees, flexion the shoulder above 90 degrees (above eye level), abduction of the shoulder 90 degrees, abduction of the shoulder above 90 degrees, doing the same movements with weight, bringing the empty glass to the mouth in a sitting position, bringing the full glass to the mouth
Modified upper extremity performance test (After intervention)After the intervention, average two weeks.Flexion the shoulder to 90 degrees, flexion the shoulder above 90 degrees (above eye level), abduction of the shoulder 90 degrees, abduction of the shoulder above 90 degrees, doing the same movements with weight, bringing the empty glass to the mouth in a sitting position, bringing the full glass to the mouth
Endurance (Before intervention)Before the intervention, up to one month.The number of knee extensions and elbow flexions they can do in sitting position in 30 seconds
Endurance (After intervention)After the intervention, average two weeks.The number of knee extensions and elbow flexions they can do in sitting position in 30 seconds
Pulmonary Dysfunction Test (Before intervention)Before the intervention, up to one month.Value when the patient counts audibly in a single expiration after maximum inspiratory effort

Secondary

MeasureTime frameDescription
Patient Satisfaction SurveyAfter the intervention average two weeksGeneral satisfaction, internet/connection, physiotherapist's guidance, timing, level of knowledge, reassurance, comfort, knowledge/advice, level of satisfaction with information clarity

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026